Ahmet Karakoyun, et al. “Increased PCSK9 Associated With CIMT in AS: A Useful Marker for Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis”. Archives of Rheumatology, vol. 39, no. 4, Dec. 2024, pp. 652-61, doi:10.46497/ArchRheumatol.2024.10625.